CH EPL (R5)
1.0.1 - trial-use Switzerland flag

This page is part of the CH EPL (R5) (v1.0.1: DSTU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

Example RegulatedAuthorization: Reimbursement SL 17418

CH EPL - Reimbursement SL

url

FOPHDossierNumber

value: FOPH Dossier Number/17418

url

status

value: Reimbursed

url

statusDate

value: 2000-04-15

url

listingStatus

value: Listed

url

listingPeriod

value: 2000-04-15 --> (ongoing)

url

firstListingDate

value: 2000-04-15

url

costShare

value: 10

url

gamme

value: Transdermal

value: CHF32.44 (CHF)

type: Ex-factory price

changeType: Price mutation after triennal review of pharmaceuticals

changeDate: 2014-11-01

url

CH EPL - Product Price

value: CHF53.65 (CHF)

type: Retail price

changeType: VAT-change

changeDate: 2024-01-01

url

CH EPL - Product Price

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-01006431-0547040020000-0097; containedItemQuantity = 24 Patch; description = ESTALIS Matrixpfl 50/250 24 Stk

type: Reimbursement SL

Indications

-ExtensionReference
*ClinicalUseDefinition: type = indication

holder: Organization Sandoz Pharmaceuticals AG

Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01006431, LOC Identifier/100054743, GLN Identifier/7601001029439

name: Sandoz Pharmaceuticals AG